[
    {
        "Company Name":"Drugs.com",
        "Domain":"drugs.com",
        "Industry":"Biotechnology Research",
        "Location":"Mumbai, India",
        "Headcount":"201-500",
        "Linkedin":"https:\/\/www.linkedin.com\/company\/appollo-pharmac",
        "Description":"Drugs.com is a pharmaceuticals company that provides a comprehensive drug database and medical information.",
        "Company Type":null,
        "Keywords":"pharmaceuticals, healthcare, medicine, pharmacy, medical information, drug database",
        "Technologies":"Google Analytics, Prebid, Google Tag Manager",
        "Tags":null,
        "Business Model":"B2C",
        "Location Score":1,
        "Headcount Score":1,
        "Industry Score":3,
        "Company Type Score":1,
        "Tech Score":0,
        "Business Score":0,
        "Total Score":6,
        "Total Score %":50.0,
        "Nouveau Directeur":"NaN",
        "Levee de Fonds":"NaN",
        "Acquisition\/Fusion":"NaN",
        "Expansion Géographique":"NaN",
        "Lancement Produit":"NaN",
        "News Score":0,
        "2024 Revenue (USD)":400000000,
        "News":"Non disponible - Aucune actualité majeure ou récente n'a été trouvée pour cette entreprise depuis septembre 2021.",
        "Date":"Non disponible"
    },
    {
        "Company Name":"Thermo Fisher Scientific",
        "Domain":"thermofisher.com",
        "Industry":"Biotechnology Research",
        "Location":"Waltham, Massachusetts, United States",
        "Headcount":"10001+",
        "Linkedin":"https:\/\/www.linkedin.com\/company\/thermo-fisher-scientific",
        "Description":"Thermo Fisher Scientific is a biotechnology company that provides scientific instruments and laboratory equipment for the life sciences and healthcare industries.",
        "Company Type":"public company",
        "Keywords":"life sciences, biotechnology, healthcare, scientific instruments, laboratory equipment",
        "Technologies":"Zurb Foundation, Akamai, Bootstrap, Lodash, Optimizely, Jquery, F5 Bigip, Sitecatalyst, Videojs, Adobe Dtm, Adobe Experience Manager",
        "Tags":null,
        "Business Model":"B2B",
        "Location Score":3,
        "Headcount Score":2,
        "Industry Score":3,
        "Company Type Score":0,
        "Tech Score":0,
        "Business Score":2,
        "Total Score":10,
        "Total Score %":84.0,
        "Nouveau Directeur":"NaN",
        "Levee de Fonds":"NaN",
        "Acquisition\/Fusion":"NaN",
        "Expansion Géographique":"NaN",
        "Lancement Produit":"NaN",
        "News Score":0,
        "2024 Revenue (USD)":30000000000,
        "News":"28 janvier 2022 - Thermo Fisher Scientific a annoncé l'acquisition de PPD, une entreprise de recherche sous contrat, pour 17,4 milliards de dollars, dans le but d'étendre ses services de recherche clinique.",
        "Date":"28 janvier 2022"
    },
    {
        "Company Name":"Agilent Technologies",
        "Domain":"agilent.com",
        "Industry":"Biotechnology Research",
        "Location":"Santa Clara, California, United States",
        "Headcount":"10001+",
        "Linkedin":"https:\/\/www.linkedin.com\/company\/agilent-technologies",
        "Description":"Agilent Technologies is a provider of laboratory equipment and analytical instruments for life sciences and scientific research.",
        "Company Type":"public company",
        "Keywords":"laboratory equipment, life sciences, biotechnology, analytical instruments, scientific research",
        "Technologies":"Ruxit, Jquery, Jquery Ui, Hogan.Js, Openssl, Google Tag Manager, Datatables, Act On, Apache, Unix, Dynatrace, Oracle Weblogic Server, Varnish, Oracle Dynamic Monitoring Service, Hsts, Bootstrap, Google Font Api",
        "Tags":null,
        "Business Model":"B2B",
        "Location Score":3,
        "Headcount Score":2,
        "Industry Score":3,
        "Company Type Score":0,
        "Tech Score":0,
        "Business Score":2,
        "Total Score":10,
        "Total Score %":84.0,
        "Nouveau Directeur":"NaN",
        "Levee de Fonds":"NaN",
        "Acquisition\/Fusion":"NaN",
        "Expansion Géographique":"NaN",
        "Lancement Produit":"NaN",
        "News Score":0,
        "2024 Revenue (USD)":5500000000,
        "News":"31 août 2021 - Agilent Technologies a annoncé l'acquisition de Resolution Bioscience, une entreprise spécialisée dans le développement de tests de séquençage génomique de nouvelle génération pour le diagnostic du cancer.",
        "Date":"31 août 2021"
    },
    {
        "Company Name":"Roche",
        "Domain":"roche.com",
        "Industry":"Biotechnology Research",
        "Location":"Switzerland",
        "Headcount":"10001+",
        "Linkedin":"https:\/\/www.linkedin.com\/company\/roche",
        "Description":"Roche is a pharmaceutical company that specializes in healthcare, diagnostics, and biotechnology.",
        "Company Type":"public company",
        "Keywords":"pharmaceuticals, biotechnology, healthcare, diagnostics, research and development",
        "Technologies":"Webpack, Amazon Web Services, Cloudflare, Storyblok, Amazon Cloudfront, React, Gatsby, Google Tag Manager, Apache Tomcat, Twitter, Youtube, Handlebars, F5 Bigip, Recaptcha, Facebook, Typekit, Jquery, Google Analytics, Moment.Js, Hammer.Js",
        "Tags":null,
        "Business Model":"B2B",
        "Location Score":0,
        "Headcount Score":2,
        "Industry Score":3,
        "Company Type Score":0,
        "Tech Score":2,
        "Business Score":2,
        "Total Score":9,
        "Total Score %":75.0,
        "Nouveau Directeur":"NaN",
        "Levee de Fonds":"NaN",
        "Acquisition\/Fusion":"NaN",
        "Expansion Géographique":"NaN",
        "Lancement Produit":"NaN",
        "News Score":0,
        "2024 Revenue (USD)":62000000000,
        "News":"23 septembre 2021 - Roche a annoncé l'approbation de la FDA pour Gavreto (pralsetinib) pour le traitement du cancer du poumon non à petites cellules avancé.",
        "Date":"23 septembre 2021"
    },
    {
        "Company Name":"23andMe",
        "Domain":"23andme.com",
        "Industry":"Biotechnology Research",
        "Location":"Sunnyvale, California, United States",
        "Headcount":"501-1000",
        "Linkedin":"https:\/\/www.linkedin.com\/company\/23andme",
        "Description":"23andMe is a genetics company that offers personalized DNA testing services for health and ancestry insights.",
        "Company Type":"public company",
        "Keywords":"genetics, health, biotechnology, personalized medicine, dna testing",
        "Technologies":"Lodash, Next.Js, Webpack, Node.Js, Jquery, New Relic, Optimizely, Cloudflare, Google Tag Manager, Facebook, Heap, React, Google Analytics, Criteo",
        "Tags":null,
        "Business Model":"B2C",
        "Location Score":3,
        "Headcount Score":0,
        "Industry Score":3,
        "Company Type Score":0,
        "Tech Score":2,
        "Business Score":0,
        "Total Score":8,
        "Total Score %":67.0,
        "Nouveau Directeur":"NaN",
        "Levee de Fonds":"NaN",
        "Acquisition\/Fusion":"NaN",
        "Expansion Géographique":"NaN",
        "Lancement Produit":"NaN",
        "News Score":0,
        "2024 Revenue (USD)":400000000,
        "News":"17 juin 2021 - 23andMe est devenue une entreprise publique après avoir finalisé une fusion avec VG Acquisition Corp, une société d'acquisition à vocation spéciale (SPAC) de Richard Branson.",
        "Date":"17 juin 2021"
    }
]